3rd Quarter - Report
FEDERAL HEALTH POLICY STRATEGIES for PFIZER
Client
Income
$60,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Drug pricing reform, H.R.3-Elijah E. Cummings Lower Drug Costs Now Act Biosimilar utilization policy S. 912/H.R. 197 S.91 the Protecting Seniors Through Immunization Act of 2021 HR 1978--Protecting Seniors Through Immunization Act of 2021 HR 5376 Inflation Reduction Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAN ELLING | — |
| COLIN ROSKEY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.